Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Riddle me this look at the last to conferences he answered shareholders questions anyone can view and see.
You can also email your questions to:
Address:
REGEN BIOPHARMA, INC.
4700 Spring Street, Suite 304
La Mesa, CA 91942
U.S.A.
Telephone: (619) 722-5505 ext: 800
Fax: (619) 330-2328
Email: david.koos@regenbiopharma.com
I know. I was just debunking the tax selling false claims and all the other misinformation we have heard all year!
Now it’s ENZC shareholders turn to prosper once again.
ENZC delivers on year end News with much more on the way and these Fudpucker Nakedshort and distort MM’s now know it.
Happy holidays to Everyone!
LoL! Looks like ENZC last run and this big Run that is jut beginning has debunked the Tax Loss Selling theory!
Last month we had a nice Run and some nice discussions about that 250%+ Recent Run without any great news like we just got along with profit taking! Profit taking for Profits is not Tax selling! LoL!
We are heading higher in 2022......year end was I right... AGAIN? smile
I'll bump this the first time we see the excuse used this year!
It's fun knowing what's coming!
KOO’s got the answers! Bring on the partners!
https://regenbiopharmainc.com/about-us/
1 IND cleared and 2 INDs submitted with the FDA.
Diverse pre-clinical pipeline including platform technologies .
Strong intellectual property protected by multiple patents
Pipeline:
https://regenbiopharmainc.com/product-pipeline/
ENZC Nakedshorted!
Naked shorting explained:
https://seekingalpha.com/article/4453048-naked-short-selling
Yep! ENZC Nakedshorted 44% yesterday and 37% today!
Short Sale Volume (Off-Exchange Provided by FINRA)
Exposing them!
2022-12-20 3,313,898 + 0 = 3,313,898 / 8,950,766 = 37.02%
2022-12-19 8,622,074 + 0 = 8,622,074 / 19,353,658 = 44.55%
https://fintel.io/ss/us/enzc
Finra is also the one that fines fines them for Nakedshorting but not very often and seems to always let them off without making them admit to it or criminal charges.
https://securitiesarbitrations.com/ubs-fined-system-failures-short-selling/
https://www.reuters.com/article/us-interactive-fine/finra-fines-interactive-brokers-5-5-million-for-short-selling-violations-idUSKCN1L525H
https://www.stocklaw.com/securities-fraud-blog/2020/october/sec-fines-morgan-stanley-5-million-over-short-sa/
Yep! ENZC Nakedshorted 44% yesterday and 37% today!
Short Sale Volume (Off-Exchange Provided by FINRA)
Exposing them!
2022-12-20 3,313,898 + 0 = 3,313,898 / 8,950,766 = 37.02%
2022-12-19 8,622,074 + 0 = 8,622,074 / 19,353,658 = 44.55%
https://fintel.io/ss/us/enzc
Latest info on newly updated web site:
https://regenbiopharmainc.com/about-us/
1 IND cleared and 2 INDs submitted with the FDA.
Diverse pre-clinical pipeline including platform technologies .
Strong intellectual property protected by multiple patents
Pipeline:
https://regenbiopharmainc.com/product-pipeline/
3 million volume in 30 minutes is good
How many shares will Fudpucker Nakedshort and distort Mm’s try to get away with today? Volume precedes Price! The great news should prevail in the long Run. More Great News on the way!
Just as suspected ENZC Nakedshorted over 44% yesterday!
(Short Sale Volume (Off-Exchange Provided by FINRA)
2022-12-19 8,622,074 + 0 = 8,622,074 / 19,353,658 = 44.55%
https://fintel.io/ss/us/enzc
Bullish
I have over 2 million shares and don’t really need anymore but after the good news yesterday. I can’t help but Pick up more cheap shares as these Fudpucker Nakedshort and distort MM’s play there games!
ENZC
Buy 100,000 Shares Limit $0.0481 Day Only 9:40 AM 12/20/2022
Bought 100,000 $0.0481 Settles 12/22/2022 9:41 AM 12/20/2022
CLOSED Filled
According to sec filings we know the 1,5 million debt was paid off in July we also know there is 510k of convertible debt to payoff, which is a drop in the bucket!
Preclinical Trials! Here is what anyone that does research instead of making false statements before they do research will find!
At present, there are no specific requirements for the reporting of preclinical research
please contact the Office of Investor Education and Advocacy at 1-800-SEC-0330 or visit the SEC´s Complaint Center
The latest:
https://www.prnewswire.com/news-releases/regen-biopharma-inc--begins-experiments-validating-its-proprietary-car-t-cell-therapy-301623585.html
Here is more RGBP preclinical facts and filing preclinical trial started in March!
While some keep claiming it would never happen! LOL!
Word!
Check it out more preclinical trials started Mar 15 2022
Submitted 15 Mar 2022 Preclinical trials in Myelodysplastic syndromes in USA (IV) (Regen Biopharma pipeline)
10 Mar 2022 Preclinical development in Breast cancer and Myelodysplastic syndrome is ongoing USA
Stay tuned much more on the way!
https://adisinsight.springer.com/drugs/800037634
I can’t wait for the FDA Fast Track! It also Looks like our NR2F6 human patent was finally granted! While some claimed it would never happen LoL!
Patent Grant 11241427
U.S. patent number 11,241,427 [Application Number 15/364,111] was granted by the patent office on 2022-02-08 for small molecule modulators of nr2f6 activity. This patent grant is currently assigned to KCL Therapeutics, Inc.. The grantee listed for this patent is Regen Biopharma, Inc.. Invention is credited to Thomas Ichim, David Koos.
FDA already granted HemaXellerate and human study was successful.
nr26f patent granted
The other IND’s activation filed is a shoe in.
No if ands or Butts about it.
RGBP has a Dream team of scientific professionals working for team RGBP and it’s not if but when! LoL!
Past human studies where also Successful! LOL!
While some claimed they would never happen or the IND’s would not get approved! LoL!
https://www.prnewswire.com/news-releases/pan-am-cancer-treatment-center-provides-final-hemaxellerate-clinical-data-to-regen-biopharma-inc-for-treatment-of-bone-marrow-suppression-study-598169731.html
In the latest data presented, the patients who apparently benefited after one month maintained their high levels of white blood cells and all 5 patients had increased numbers of white blood cells after 6 months as compared to after 1 month. In addition, all 5 patients had increased numbers of red blood cells and increased numbers of platelets 6 months after treatment as compared to after 1 month.
Now RGBP has much more going for us!
Regen BioPharma Inc's Company Profile
Business Description
Regen BioPharma Inc is a US-based biotechnology company. It focuses on the development of regenerative medical applications in the stem cell space. The company's principal products and services include HemaXellarate I, HemaXellerate II, dCell Vax, NR2F6, Tcellvax, identification of Small Molecules, and others. HemaXellarate I and HemaXellerate II is a cellular therapy designed to heal damaged bone marrow. dCell Vax is a therapy whereby dendritic cells of the cancer patient are harvested from the body. Tcellvax is an autologous cellular product comprised of NR2F6 gene-silenced peripheral blood mononuclear cells.
Just as suspected ENZC Nakedshorted over 44% today!
(Short Sale Volume (Off-Exchange Provided by FINRA)
2022-12-19 8,622,074 + 0 = 8,622,074 / 19,353,658 = 44.55%
https://fintel.io/ss/us/enzc
For a dose of reality, I’m sure todays ENZC News will cause more vacations, time off or sick days!
Mic Drop! Silence!
https://www.otcmarkets.com/stock/ENZC/news/Enzolytics-Inc-Announces-the-Completion-of-the-2020-and-2021-Audited-Financials?id=384232
Last years 1.5 debt was paid off in July just as was claimed.
proof with link below.
The principal balance and accrued interest payable remaining on the $1,500,000 promissory note issued to Coventry Enterprises LLC are both $0 as of July 19,2022.
https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&ref=116832158&type=PDF&symbol=RGBP&companyName=Regen+Biopharma+Inc&formType=8-K&formDescription=Current+report+pursuant+to+Section+13+or+15%28d%29&dateFiled=2022-07-20&CK=1589150
Yes most here think KOO’s would have no problem getting 5 million dollars. When he personally owns 169 million preferred shares. LoL!
Not to be confused with the 50 million dollar deal that was declined. LoL!
Yes RGBP hit 8 cents not once but twice last year making Traders much Bank!
Can it do it again? Time will tell!
Cherry picking a time frame of 15 months and claiming RGBP is down 94% is hilarious. When RGBP had many 50% to 20,000% runs the last couple of years. LoL! In all reality any real investor who bought the trips before that cherry picked time frame like Myself and many others are up over 1,000% on those shares and many of us sold part of our shares for up to 20,000%. LoL!
Do the math and see anyone that held is still up over 1,000%
10,000,000 shares at . 0004 = $4,000
10,000,000 shares at . 0042 = $42,000
10,000,000 shares at . 0813 = $813,000
We got not one but two 1,000% to 20,000% opportunities last year to sell and 10 or more 50% to 350% runs this year.
RGBP has been a Traders Dream!
Who believes these calls or false claims of being Right! ! LoL!
Who remembers all the disinformation when we where told Landers would never work with KOO’s again. Yet the latest conferences proves he is. just like all these others thing that happened right after we where told they would never happen. LoL!
Remember when we where told RGBP would never leave the trips let alone hit a penny right before it did and even after being shorted down. Who remembers we where told it would never reach copper again right before it ran to 8 cents the first time last year. Who remembers after the next short down 4 months later RGBP ran to over 8 cents again for two 1,000% to 20,000% Big Fun Runs LoL!
Who remembers this May when RGBP was shorted down to its low of . 0034 that we where told it would never recover and only go lower, right before it had another 350% run LoL!
Who remembers we where told RGBP would never get Current right before it did LoL!
Who remembers we where told RGBP would never get a deal with ONPH right before RGBP got 2 deals. Making much bank. LoL!
Who remembers we where told Chemdiv would never settle with RGBP
Right before they did. LoL!
Who remembers we where told chemdiv would not only sue RGBP in court, but chemdiv would bankrupt RGBP and put them out of business and chemdiv would get there patents.
Right before chemdiv settled for $400k less than they where trying to over charge RGBP for the lab work and steal the patents! LoL!
They settle for $400k less than they claimed RGBP owed them because they knew they where trying to over charge and The Court and Judge would not not buy there false claim. LoL!
RGBP won and won Big! LoL!
Who remembers who said all these things?
RGBP and IHUB history tells the story and how wrong those that made these false claims where! LoL!
WRONG! LoL! Ongoing Agreement With Eli Lilly Leads to Discovery of Several New Small Molecule Drugs
https://www.hvst.com/posts/ongoing-agreement-with-eli-lilly-leads-to-discovery-of-several-new-small-molecule-drugs-wm4T1ZDp
Rgbp Longs are in it to Win it as anyone who understands otc stocks knows!
For Fudpucker Nakedshort and distort MM’s overtime for a few more
Peanut butter and Jelly sandwiches until the next Big Fun RGBP Run!
Then they will go without as they get desperately hungry as they are Naked and Afraid!
Just as suspected RGBP nakedshorted over 62% again Today!
RGBP has been heavily Nakedshorted!
Fintel Short Sale Volume (Off-Exchange Provided by FINRA) is exposing
Them
2022-12-16 3,445,395 + 0 = 3,445,395 / 5,495,699 = 62.69%
2022-12-15 10,602,725 + 0 = 10,602,725 / 15,189,435 = 69.80%
https://fintel.io/ss/us/rgbp
Just as suspected RGBP nakedshorted over 62% again Today!
RGBP has been heavily Nakedshorted!
Fintel Short Sale Volume (Off-Exchange Provided by FINRA) is exposing
Them
2022-12-16 3,445,395 + 0 = 3,445,395 / 5,495,699 = 62.69%
2022-12-15 10,602,725 + 0 = 10,602,725 / 15,189,435 = 69.80%
https://fintel.io/ss/us/rgbp
Preclinical Trials! Here is what anyone that does research instead of making false statements before they do research will find!
At present, there are no specific requirements for the reporting of preclinical research
please contact the Office of Investor Education and Advocacy at 1-800-SEC-0330 or visit the SEC´s Complaint Center
The latest:
https://www.prnewswire.com/news-releases/regen-biopharma-inc--begins-experiments-validating-its-proprietary-car-t-cell-therapy-301623585.html
Here is more RGBP preclinical facts and filing preclinical trial started in March!
While some keep claiming it would never happen! LOL!
Word!
Check it out more preclinical trials started Mar 15 2022
Submitted 15 Mar 2022 Preclinical trials in Myelodysplastic syndromes in USA (IV) (Regen Biopharma pipeline)
10 Mar 2022 Preclinical development in Breast cancer and Myelodysplastic syndrome is ongoing USA
Stay tuned much more on the way!
https://adisinsight.springer.com/drugs/800037634
I can’t wait for the FDA Fast Track! It also Looks like our NR2F6 human patent was finally granted! While some claimed it would never happen LoL!
Patent Grant 11241427
U.S. patent number 11,241,427 [Application Number 15/364,111] was granted by the patent office on 2022-02-08 for small molecule modulators of nr2f6 activity. This patent grant is currently assigned to KCL Therapeutics, Inc.. The grantee listed for this patent is Regen Biopharma, Inc.. Invention is credited to Thomas Ichim, David Koos.
FDA already granted HemaXellerate and human study was successful.
nr26f patent granted
The other IND’s activation filed is a shoe in.
No if ands or Butts about it.
RGBP has a Dream team of scientific professionals working for team RGBP and it’s not if but when! LoL!
Past human studies where also Successful! LOL!
While some claimed they would never happen or the IND’s would not get approved! LoL!
https://www.prnewswire.com/news-releases/pan-am-cancer-treatment-center-provides-final-hemaxellerate-clinical-data-to-regen-biopharma-inc-for-treatment-of-bone-marrow-suppression-study-598169731.html
In the latest data presented, the patients who apparently benefited after one month maintained their high levels of white blood cells and all 5 patients had increased numbers of white blood cells after 6 months as compared to after 1 month. In addition, all 5 patients had increased numbers of red blood cells and increased numbers of platelets 6 months after treatment as compared to after 1 month.
Now RGBP has much more going for us!
Regen BioPharma Inc's Company Profile
Business Description
Regen BioPharma Inc is a US-based biotechnology company. It focuses on the development of regenerative medical applications in the stem cell space. The company's principal products and services include HemaXellarate I, HemaXellerate II, dCell Vax, NR2F6, Tcellvax, identification of Small Molecules, and others. HemaXellarate I and HemaXellerate II is a cellular therapy designed to heal damaged bone marrow. dCell Vax is a therapy whereby dendritic cells of the cancer patient are harvested from the body. Tcellvax is an autologous cellular product comprised of NR2F6 gene-silenced peripheral blood mononuclear cells.
2021-10-12
Application granted
Status
Active
2037-10-05
Adjusted expiration
https://patents.google.com/patent/US20170304418A1/en
More patents
https://www.biospace.com/article/releases/regen-biopharma-inc-responds-to-numerous-requests-for-updates-on-its-intellectual-property-ip-portfolio/
Also
In 2021 the Company was granted US patent # 11,090,332 on composition of matter of survivin modified-mRNA useful for teaching the immune system to kill cancer. In the current patent, specific types of dendritic cells, means of generating specialized dendritic cells, and the planned formulation that will enter clinical trials have been granted patent protection.
https://www.prnewswire.com/news-releases/regen-biopharma-inc--files-provisional-patent--application-on-second-generation-survivin-mrna-cancer-immunotherapy-vaccine-301593795.html
Wrong! I post links! For the facts and truth, I suggest to look at the latest RGBP filings along with the new RGBP website!
Anyone can also contact KOO’s or the company
https://regenbiopharmainc.com/contact-us/
Telephone: (619) 722-5505 ext: 800
Fax: (619) 330-2328
Email: david.koos@regenbiopharma.com
Click here and scroll down:
https://regenbiopharmainc.com/product-pipeline/
1 IND cleared and 2 INDs submitted with the FDA.
Diverse pre-clinical pipeline including platform technologies .
Strong intellectual property protected by multiple patents
Also check out RGBP’s Dream Team and intellectual property:
https://regenbiopharmainc.com/about-us/
Misinformation is just that misinformation!
Why would anyone make false claims that can easily be proven wrong with facts, filings, links, news and DD. LoL!
Who remembers all the disinformation when we where told Landers would never work with KOO’s again. Yet the lasted conferences proves he is. just like all these others thing that happened right after we where told they would never happen. LoL!
Remember when we where told RGBP would never leave the trips let alone hit a penny right before it did and even after being shorted down. Who remembers we where told it would never reach copper again right before it ran to 8 cents the first time last year. Who remembers after the next short down 4 months later RGBP ran to over 8 cents again for two 1,000% to 20,000% Big Fun Runs LoL!
Who remembers this May when RGBP was shorted down to its low of . 0034 that we where told it would never recover and only go lower, right before it had another 350% run LoL!
Who remembers we where told RGBP would never get Current right before it did LoL!
Who remembers we where told RGBP would never get a deal with ONPH right before RGBP got 2 deals. Making much bank. LoL!
Who remembers we where told Chemdiv would never settle with RGBP
Right before they did. LoL!
Who remembers we where told chemdiv would not only sue RGBP in court, but chemdiv would bankrupt RGBP and put them out of business and chemdiv would get there patents.
Right before chemdiv settled for $400k less than they where trying to over charge RGBP for the lab work and steal the patents! LoL!
They settle for $400k less than they claimed RGBP owed them because they knew they where trying to over charge and The Court and Judge would not not buy there false claim. LoL!
RGBP won and won Big! LoL!
Who remembers who said all these things?
RGBP and IHUB history tells the story and how wrong those that made these false claims where! LoL!
RGBP has been heavily Nakedshorted. The misinformation is claiming Nakedshorting isn’t out there when there is plenty of Proof to show it is. LoL!
Google it! There is plenty of information out there.
Long story short.
It’s kind a like the Fox Guarding the Hen house with a few slap on the wrist fines every now and again for show!
https://www.financemagnates.com/institutional-forex/finra-penalizes-ubs-securities-25m-for-73000-naked-short-sales/
https://www.wsj.com/articles/interactive-brokers-fined-5-5-million-for-naked-short-selling-violations-1534797834
RGBP I’m in it to win It!
https://www.reuters.com/article/southkorea-goldman-sachs/south-korea-fines-goldman-sachs-unit-6-7-million-for-naked-short-selling-idINKCN1NX0LW
Take that up with Finra the agency that actually exposes these Fudpucker Nakedshort and distort MM’s and actually fines them ever now and again!
The question is, Is why don’t they just stop all shorting and really fix the Problem?
Just as suspected RGBP nakedshorted over 69% again Yesterday and still closed up over 7%
RGBP has been heavily Nakedshorted!
Fintel Short Sale Volume (Off-Exchange Provided by FINRA) is exposing
Them
2022-12-15 10,602,725 + 0 = 10,602,725 / 15,189,435 = 69.80%
https://fintel.io/ss/us/rgbp
Just as suspected RGBP nakedshorted over 69% again Today and still closed up over 7%
RGBP has been heavily Nakedshorted!
Fintel Short Sale Volume (Off-Exchange Provided by FINRA) is exposing
Them
2022-12-15 10,602,725 + 0 = 10,602,725 / 15,189,435 = 69.80%
https://fintel.io/ss/us/rgbp
Did anyone notice that RGBP closed up over 7% today even with heavy Nakedshorting and claims of at a new 1 month low! LoL! More fun to come!
Smart, Experienced, knowledgeable Traders know
Finra is the #1 and the most trusted source for Short Sale Volume
(Off-Exchange Provided by FINRA)
https://fintel.io/ss/us/rgbp
Wrong! Short Sale Volume (Off-Exchange Provided by FINRA)
Finra is also the one that fines the corrupt Fudpucker Nakedshorts and distort MM’s! LoL
Chart shows RGBP up over 7% today even with all the Nakedshortsing! LoL!
Buy the dips sell the Ripping Runs,
RGBP has had 10 or more 50% to 350% runs this year so far! LoL!
RGBP is a Traders Dream!
Short Sale Volume (Off-Exchange Provided by FINRA)
2022-12-14 3,896,923 + 0 = 3,896,923 / 7,992,915 = 48.75%
2022-12-13 3,251,202 + 0 = 3,251,202 / 8,673,478 = 37.48%
2022-12-12 2,669,326 + 0 = 2,669,326 / 5,868,885 = 45.48%
2022-12-09 3,220,857 + 0 = 3,220,857 / 7,664,940 = 42.02%
2022-12-08 2,930,116 + 0 = 2,930,116 / 5,052,500 = 57.99%
2022-12-07 8,018,297 + 0 = 8,018,297 / 11,949,078 = 67.10%
2022-12-06 5,555,399 + 0 = 5,555,399 / 8,088,912 = 68.68%
2022-12-02 10,550,228 + 0 = 10,550,228 / 17,309,090 = 60.95%
2022-12-01 16,988,496 + 0 = 16,988,496 / 25,885,282 = 65.63
2022-11-30 9,561,308 + 0 = 9,561,308 / 15,033,421 = 63.60%
https://fintel.io/ss/us/rgbp
Did anyone notice RGBP has been heavily Naked shorted all year yet RGBP has still had 10 or more 50% to 350% runs.
Smart traders while holding a core position buy extra shares on these dips and sale them on the many RGBP Fun Runs.
Wash, Rinse and Repeat for big profits and free Riding share.
https://fintel.io/ss/us/rgbp
RGBP has a great scientific Dream Team along with a nice Pipeline:
https://regenbiopharmainc.com/product-pipeline/
Wrong! I post links! For the facts and truth, I suggest to look at the latest RGBP filings along with the new RGBP website!
Anyone can also contact KOO’s or the company
https://regenbiopharmainc.com/contact-us/
Telephone: (619) 722-5505 ext: 800
Fax: (619) 330-2328
Email: david.koos@regenbiopharma.com
Click here and scroll down:
https://regenbiopharmainc.com/product-pipeline/
1 IND cleared and 2 INDs submitted with the FDA.
Diverse pre-clinical pipeline including platform technologies .
Strong intellectual property protected by multiple patents
Also check out RGBP’s Dream Team and intellectual property:
https://regenbiopharmainc.com/about-us/
Misinformation is just that misinformation!
Why would anyone make false claims that can easily be proven wrong with facts, filings, links, news and DD. LoL!
Misinformation is just that misinformation!
RGBP has 1 Ind approved and 2 submitted with ongoing preclinical trials.
https://regenbiopharmainc.com/product-pipeline/
Ongoing preclinicals:
https://www.prnewswire.com/news-releases/regen-biopharma-inc-progresses-its-duracar-therapeutic-301682553.html
News and updates!
https://regenbiopharmainc.com/company-news/
Now that’s Funny! First we hear KOO’s will not answer shareholders questions and then when he does we hear infamous denials of what we just heard on the conference.
Everyone that witnessed the conference knows the truth and those that did not listen can hear the replay and see the truth!
Misinformation is just that misinformation!
Check out MM ETRF’s big 3.8 million bid and and there small 147k ask as they try and steal shares!
Fudpucker Nakedshort and distort MM’s have heavily Nakedshorted RGBP but are still not successful in keeping it down!
RGBP has been a traders Dream with 10 or more 50% to 350% runs this year alone, along with 2 big fun Runs last year
What kind of things would a ENZC Fudpucker Nakedshort and distort MM say as they Nakedshort and distort? LoL!
“Instead of being excited and buying, maybe see it as a chance to cut losses and sell”
https://www.accesswire.com/731575/Enzolytics-Inc-Announces-US-Distribution-of-IPF-ImmuneTM-and-Progress-in-each-of-its-Therapeutic-Platforms
IPF is launched and being purchased! LoL!
Months ahead would include December! LoL!
Note, we're not launching it in the months ahead, but instead, planning to! Remember the difference between launching and planning to launch?
All them False claims it’s would not happen and the onelavi deal expired have been proven wrong Wrong! LoL!
Mic Drop!
https://www.accesswire.com/731575/Enzolytics-Inc-Announces-US-Distribution-of-IPF-ImmuneTM-and-Progress-in-each-of-its-Therapeutic-Platforms
It is launched and being purchased!
Quote:
Note, we're not launching it in the months ahead, but instead, planning to! Remember the difference between launching and planning to launch? Wasn't planning to launch IPF snake oil in March 2022 humiliating enough for everyone? How about it being "available in the USA by November?" Fool me three times, shame on......? LOL
Integrity is delivering the product. When some claimed it would never happen!
We all see how them false claims worked out! LoL!
Really ridiculous to think anything but INTEGRITY with Charles C and Team .
Loving theses cheap shares!
RGBP
Buy 777,777 Shares Limit $0.0042 Expires on 02/13/2023 12:54 PM 12/13/2022
Bought 246,242 $0.0042 Settles 12/15/2022 12:54 PM 12/13/2022
OPEN Partial Fill
This live, interactive online event will give existing shareholders and the investment community the opportunity to interact with the Company's CEO, Dr. David Koos, in real time. Please ask your questions during the event and Dr. Koos and his team will do their best to get through as many of them as possible.
https://www.benzinga.com/pressreleases/22/12/n30048399/regen-biopharma-inc-to-present-at-the-emerging-growth-conference-on-december-14-2022
Getting them while there cheap! Before the next big News, Deal, Partner Or Buyout!
RGBP
Buy 999,999 Shares Limit $0.0043 Expires on 02/13/2023 12:33 PM 12/13/2022
Bought 600,000 $0.0043 Settles 12/15/2022 12:34 PM 12/13/2022
Bought 207,907 $0.0043 Settles 12/15/2022 12:34 PM 12/13/2022
OPEN Partial Fill
This live, interactive online event will give existing shareholders and the investment community the opportunity to interact with the Company's CEO, Dr. David Koos, in real time. Please ask your questions during the event and Dr. Koos and his team will do their best to get through as many of them as possible.
https://www.benzinga.com/pressreleases/22/12/n30048399/regen-biopharma-inc-to-present-at-the-emerging-growth-conference-on-december-14-2022
Just as suspected they finally updated! RGBP still heavily Naked shorted!
Short Sale Volume (Off-Exchange Provided by FINRA)
https://fintel.io/ss/us/rgbp
2022-12-12 2,669,326 + 0 = 2,669,326 / 5,868,885 = 45.48%
2022-12-09 3,220,857 + 0 = 3,220,857 / 7,664,940 = 42.02%
2022-12-08 2,930,116 + 0 = 2,930,116 / 5,052,500 = 57.99%
2022-12-07 8,018,297 + 0 = 8,018,297 / 11,949,078 = 67.10%
2022-12-06 5,555,399 + 0 = 5,555,399 / 8,088,912 = 68.68%
2022-12-02 10,550,228 + 0 = 10,550,228 / 17,309,090 = 60.95%
2022-12-01 16,988,496 + 0 = 16,988,496 / 25,885,282 = 65.63%
2022-11-30 9,561,308 + 0 = 9,561,308 / 15,033,421 = 63.60%
2022-11-29 15,857,565 + 0 = 15,857,565 / 22,134,720 = 71.64%
2022-11-28 7,560,550 + 0 = 7,560,550 / 10,523,829 = 71.84%